Friday, January 24, 2014

BioVax: Vaccine for Follicular Lymphoma (In Eurpoe?)

First off, my shoulder: got the results of my MRI, and I have a torn tendon in my rotator cuff. (I've been avoiding words like "torn" when I tell most people this, but I don't think cancer patients and their loved ones are among the squeamish, so I'm going for it). It means I'll need surgery, and then six weeks in a sling. Still not sure how all that will affect either my job or my blogging, but I'll know more in about 10 days. Surgery won't be for at least a few weeks, so I'll keep plugging away as well as I can for now.


Given what that article from my last post said about vaccines, I thought it was interesting that BioVaxID, an attempt at a lymphoma vaccine, was being considered for approval for use against NHL by the European Union.

I've been interested by BioVax because it was mentioned by Dr. C, the lymphoma specialist that I saw six years ago, right after I was diagnosed. He was very excited about it way back then (six years is like an eternity in lymphoma research), though it has had mixed results in clinical trials, at least for treating Follicular Lymphoma.

That was a little disappointing to me. And I'm not sure if BioVax is included in the vaccines that people are getting so excited about. My guess is not, considering that it's been around for about 10 years and still hasn't been deemed a success.

But it also seems like it was a necessary step in the right direction, and now we know more about what made it less successful than we would have liked. So maybe we another form of it sometime in the future?

Whatever the case, we have lots of promising options in the pipeline, and it will be fun to see where we go from here.

No comments: